文献速递血液净化与透析

血液透析中的液体容量管理:永不放弃!

Fluid volume management in hemodialysis: never give up!
PubMed 文献 · Kidney Int · 2023-01-01

本文回顾了法国Tassin的「探查干体重」概念及历史结局,指出近期肺超声引导干体重评估试验的主要终点为阴性,且基于生物阻抗纠正容量超负荷的前瞻性研究Meta分析未显示对全因死亡率有直接效应;作者提出应综合体重、血压、生物阻抗、透析液团注绝对血容量及肺超声等多维信息,在机器学习时代采用每日调整的灵活目标体重处方,作为「永不放弃」的液体管理路径。

要点

  • Tassin历史队列在1980年代死亡率优于登记数据,但现今与欧洲平均水平相似。
  • 肺超声引导干体重评估的近期试验主要终点为阴性。
  • 基于生物阻抗纠正容量超负荷的前瞻性研究Meta分析未显示对全因死亡率有直接效应。

核心结论

  • 鉴于血液透析液体管理相关前瞻性研究均为阴性结果,作者提出「永不放弃」的多维信息整合与灵活目标体重管理路径。

研究设计与样本

  • 本文为综述,回顾「探查干体重」概念的历史实例并讨论近期试验与Meta分析证据。

主要发现

  • 法国Tassin采用「探查干体重」并实践「长时慢透析」,1980年代死亡率优于登记数据,但现今与欧洲平均水平相似。
  • 近期基于肺超声引导评估肺内液体过多以确定干体重的试验主要终点为阴性。
  • 前瞻性研究的Meta分析未能显示基于生物阻抗纠正容量超负荷的干预对全因死亡率有直接效应。

临床怎么用

  • 临床推理要求尽可能收集透析患者液体状态的多方面信息。
  • 除体重和血压外,生物阻抗和透析液团注衍生的绝对血容量原则上可自动化测量,肺超声可常规获取。
  • 在机器学习时代,液体管理可包括灵活的目标体重处方,每日调整并考虑无脂体重波动。
  • 作者提出将上述综合管理作为「永不放弃」的路径。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Every hemodialysis session starts with the question of how much fluid should be removed, which can currently not be answered precisely. Herein, we first revisit the "probing-dry-weight" concept, using the historical example of Tassin/France (practicing also "long, slow dialysis"): Mortality outcomes were, in the 1980s, better than registry data, but are nowadays similar to European average. In view of the negative primary end point in a recent trial on dry weight assessment, based on lung ultrasound-guided evaluation of fluid excess in the lungs, and a meta-analysis of prospective studies failing to show that bioimpedance-based interventions for correction of volume overload had a direct effect on all-cause mortality, we ask how to ever move forward. Clinical reasoning demands that as much information as possible should be gathered on the fluid status of patients undergoing dialysis. Besides body weight and blood pressure, measurements of bioimpedance and dialysate bolus-derived absolute blood volume can in principle be automatized, whereas lung ultrasound can be obtained routinely. In the era of machine learning, fluid management could consist of flexible target weight prescriptions, adjusted on a daily basis and accounting even for fluctuations in fluid-free body mass. In view of all the negative prospective results surrounding fluid management in hemodialysis, we propose this as a "never-give-up" approach.

来源:Kidney Int,查看原文。版权归原作者所有。

引用

  1. Hecking M, Madero M, Port FK, et al. Fluid volume management in hemodialysis: never give up! Kidney Int. 2023. PMID: 36603969. doi:10.1016/j.kint.2022.09.021

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。